Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Endocrinology 2006
FDA (2022) FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections
In a double-blind study, 40 PVD patients were given either reduced active glutathione (GSH) IV infusions twice a day or placebo
Design, synthesis, and biological activity of peptides which release growth hormone in vitro
Biological concern for PDAC based on preclinical studies In 2005, exenatide, the first GLP-1RA was marketed as treatment for T2D
US$ 26.00
US$ 24.44
US$ 25.21
US$ 20.94
US$ 28.20
